FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019293853> ?p ?o ?g. }

• W2019293853 endingPage "208" @default.
• W2019293853 startingPage "204" @default.
• W2019293853 abstract "Objective. To determine the association of race with incidence, histology, treatment, and survival in women with uterine sarcoma during the period 1989–1999. Methods. Uterine sarcomas were defined as leiomyosarcoma, carcinosarcoma, high-grade endometrial stromal sarcoma (HGESS), adenosarcoma, and sarcoma not otherwise specified (NOS). We used cases from Surveillance, Epidemiology, and End Results (SEER) program to compare uterine sarcoma among women >35 years of age. Using data from 1989 to 1999, we compared race-specific age-adjusted incidences, histological distributions, extent of disease at diagnosis, and race-specific survival. Results. During the period of 1989–1999, 2677 women were diagnosed with uterine sarcoma, 2098 (78%) of whom were white and 420 (16%) of whom were black, and 159 (6%) of whom were of other races. The overall age-adjusted incidence for blacks was twice that of whites and more than twice that of women of other races (7/105 vs. 3.6/105 vs. 2.7/105, P < 0.0001). Racial differences in the incidence of uterine sarcoma existed for leiomyosarcoma (1.51/105 for blacks vs. 0.91/105 for whites, and 0.89 for women of other races, P < 0.01) and carcinosarcoma (4.3/105 for blacks, vs. 1.7/105 for whites, and 0.99 for women of other races, P < 0.001), but not for other histological types. Blacks with stage II disease were less likely to receive radiation in addition to surgery compared to whites (33% vs. 54%, P < 0.05). Five-year relative survival of patients with disease beyond the uterus was significantly longer for those that received radiation and surgery compared to those that received surgery alone. There were no racial differences in survival for women that received similar therapy. Conclusions. Adjuvant therapy improved survival for women with stage II–IV disease. Survival of black and white patients who received comparable treatment was similar." @default.
• W2019293853 created "2016-06-24" @default.
• W2019293853 creator A5002903482 @default.
• W2019293853 creator A5049494659 @default.
• W2019293853 creator A5061795876 @default.
• W2019293853 creator A5067722726 @default.
• W2019293853 date "2004-04-01" @default.
• W2019293853 modified "2023-10-09" @default.
• W2019293853 title "Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999" @default.
• W2019293853 cites W1536386769 @default.
• W2019293853 cites W1966048683 @default.
• W2019293853 cites W1970950714 @default.
• W2019293853 cites W2001564888 @default.
• W2019293853 cites W2021752975 @default.
• W2019293853 cites W2034257012 @default.
• W2019293853 cites W2045662163 @default.
• W2019293853 cites W2075280048 @default.
• W2019293853 cites W2084944314 @default.
• W2019293853 cites W4255462719 @default.
• W2019293853 cites W4296028806 @default.
• W2019293853 doi "https://doi.org/10.1016/j.ygyno.2003.12.029" @default.
• W2019293853 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15047237" @default.
• W2019293853 hasPublicationYear "2004" @default.
• W2019293853 type Work @default.
• W2019293853 sameAs 2019293853 @default.
• W2019293853 citedByCount "442" @default.
• W2019293853 countsByYear W20192938532012 @default.
• W2019293853 countsByYear W20192938532013 @default.
• W2019293853 countsByYear W20192938532014 @default.
• W2019293853 countsByYear W20192938532015 @default.
• W2019293853 countsByYear W20192938532016 @default.
• W2019293853 countsByYear W20192938532017 @default.
• W2019293853 countsByYear W20192938532018 @default.
• W2019293853 countsByYear W20192938532019 @default.
• W2019293853 countsByYear W20192938532020 @default.
• W2019293853 countsByYear W20192938532021 @default.
• W2019293853 countsByYear W20192938532022 @default.
• W2019293853 countsByYear W20192938532023 @default.
• W2019293853 crossrefType "journal-article" @default.
• W2019293853 hasAuthorship W2019293853A5002903482 @default.
• W2019293853 hasAuthorship W2019293853A5049494659 @default.
• W2019293853 hasAuthorship W2019293853A5061795876 @default.
• W2019293853 hasAuthorship W2019293853A5067722726 @default.
• W2019293853 hasConcept C107130276 @default.
• W2019293853 hasConcept C120665830 @default.
• W2019293853 hasConcept C121332964 @default.
• W2019293853 hasConcept C126322002 @default.
• W2019293853 hasConcept C141071460 @default.
• W2019293853 hasConcept C142724271 @default.
• W2019293853 hasConcept C146357865 @default.
• W2019293853 hasConcept C151730666 @default.
• W2019293853 hasConcept C2777532014 @default.
• W2019293853 hasConcept C2777546739 @default.
• W2019293853 hasConcept C2777590123 @default.
• W2019293853 hasConcept C2778256501 @default.
• W2019293853 hasConcept C2778527826 @default.
• W2019293853 hasConcept C2778938455 @default.
• W2019293853 hasConcept C2779391198 @default.
• W2019293853 hasConcept C2780057860 @default.
• W2019293853 hasConcept C2780558122 @default.
• W2019293853 hasConcept C29456083 @default.
• W2019293853 hasConcept C61511704 @default.
• W2019293853 hasConcept C71924100 @default.
• W2019293853 hasConcept C86803240 @default.
• W2019293853 hasConceptScore W2019293853C107130276 @default.
• W2019293853 hasConceptScore W2019293853C120665830 @default.
• W2019293853 hasConceptScore W2019293853C121332964 @default.
• W2019293853 hasConceptScore W2019293853C126322002 @default.
• W2019293853 hasConceptScore W2019293853C141071460 @default.
• W2019293853 hasConceptScore W2019293853C142724271 @default.
• W2019293853 hasConceptScore W2019293853C146357865 @default.
• W2019293853 hasConceptScore W2019293853C151730666 @default.
• W2019293853 hasConceptScore W2019293853C2777532014 @default.
• W2019293853 hasConceptScore W2019293853C2777546739 @default.
• W2019293853 hasConceptScore W2019293853C2777590123 @default.
• W2019293853 hasConceptScore W2019293853C2778256501 @default.
• W2019293853 hasConceptScore W2019293853C2778527826 @default.
• W2019293853 hasConceptScore W2019293853C2778938455 @default.
• W2019293853 hasConceptScore W2019293853C2779391198 @default.
• W2019293853 hasConceptScore W2019293853C2780057860 @default.
• W2019293853 hasConceptScore W2019293853C2780558122 @default.
• W2019293853 hasConceptScore W2019293853C29456083 @default.
• W2019293853 hasConceptScore W2019293853C61511704 @default.
• W2019293853 hasConceptScore W2019293853C71924100 @default.
• W2019293853 hasConceptScore W2019293853C86803240 @default.
• W2019293853 hasIssue "1" @default.
• W2019293853 hasLocation W20192938531 @default.
• W2019293853 hasLocation W20192938532 @default.
• W2019293853 hasOpenAccess W2019293853 @default.
• W2019293853 hasPrimaryLocation W20192938531 @default.
• W2019293853 hasRelatedWork W111551809 @default.
• W2019293853 hasRelatedWork W1984243485 @default.
• W2019293853 hasRelatedWork W2002213980 @default.
• W2019293853 hasRelatedWork W2019293853 @default.
• W2019293853 hasRelatedWork W2319815263 @default.
• W2019293853 hasRelatedWork W2362722327 @default.
• W2019293853 hasRelatedWork W2364304342 @default.
• W2019293853 hasRelatedWork W2414897167 @default.

• next